Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-02-24
- Last Posted Date
- 2019-05-21
- Lead Sponsor
- Cristiana Sessa
- Target Recruit Count
- 17
- Registration Number
- NCT02069158
- Locations
- 🇨ðŸ‡
Oncology Institute of Southern Switzerland (IOSI), Bellinzona, TI, Switzerland
Study of Inotuzumab Ozogamicin + Temsirolimus in Patients With Relapsed or Refractory CD22+ B-cell NHLymphoma
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-02-20
- Last Posted Date
- 2016-06-07
- Lead Sponsor
- Cristiana Sessa
- Target Recruit Count
- 25
- Registration Number
- NCT01535989
- Locations
- 🇨ðŸ‡
Oncology Institute of Southern Switzerland, Bellinzona, Ticino, Switzerland
🇨ðŸ‡InselSpital, Universitätsspital Bern, Bern, Switzerland
🇨ðŸ‡Kantonsspital St.Gallen, San Gallen, Switzerland
© Copyright 2024. All Rights Reserved by MedPath